Literature DB >> 23949457

Clinical-pathological discrepancies in critically ill patients with difficult premortem diagnoses.

Aline Fusco Fares, Patrícia Maluf Cury, Suzana Margareth Lobo.   

Abstract

INTRODUCTION: The importance of autopsies is a common theme of discussions both in Brazil and around the world as it elucidates causes of death and has wide ranging social value. However this is a practice that is gradually being considered unnecessary and there have been a decline in the number of postmortems examinations.
OBJECTIVES: To compare clinical and pathological diagnosis in critically ill patients with difficult premortem diagnosis.
METHODS: All autopsy cases (total of 98) from any of the three general medical/surgical intensive care units (78 beds in total) affiliated to the medical school from January 2003 to December 2006 were analyzed. We analyzed the clinical and pathological diagnosis based on the Goldman criteria.
RESULTS: In 49 (50%) cases, there were class I and II of Goldman. In contrast, only 30 (30.6%) had a complete agreement between premortem and postmortem diagnosis and were classified as class V. Infections had a significantly greater rate of concordant diagnosis than cardiovascular diseases.
CONCLUSION: We found significant discrepancies between clinical and pathological findings, reinforcing the value of postmortem examination.

Entities:  

Year:  2011        PMID: 23949457

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  2 in total

1.  The medical autopsy as quality assurance tool in clinical medicine: dreams and realities.

Authors:  Jan G van den Tweel; Christian Wittekind
Journal:  Virchows Arch       Date:  2015-08-28       Impact factor: 4.064

2.  Deontological examination as a criterion for the assessment of personal healthcare professional quality: A Strobe compliant retrospective study.

Authors:  Sandra Mazeikiene; Jurgita Stasiuniene; Diana Vasiljevaite; Sigitas Laima; Sigitas Chmieliauskas; Dmitrij Fomin; Rokas Simakauskas; Algimantas Jasulaitis
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.